NO20050037L - Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein - Google Patents

Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein

Info

Publication number
NO20050037L
NO20050037L NO20050037A NO20050037A NO20050037L NO 20050037 L NO20050037 L NO 20050037L NO 20050037 A NO20050037 A NO 20050037A NO 20050037 A NO20050037 A NO 20050037A NO 20050037 L NO20050037 L NO 20050037L
Authority
NO
Norway
Prior art keywords
reactive protein
interaction
hts
test system
components
Prior art date
Application number
NO20050037A
Other languages
Norwegian (no)
Inventor
Aimo Kannt
Antje Pommereau
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20050037L publication Critical patent/NO20050037L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det er beskrevet en fremgangsmåte og et testsystem som er i stand til HTS for bestemmelse av vekselvirkningen mellom C-reaktivt protein (CRP) henholdsvis Clq og til CRP henholdsvis Clq bindende komponenter, for konsentrasjonsbestemmelse av en CRP- henholdsvis Clq-holdig oppløsning samt for bestemmelse av stoffer som påvirker interaksjonen av CRP henholdsvis Clq og til disse bindende komponentene, spesielt vekselvirkningen mellom CRP og Clq.There is disclosed a method and test system capable of HTS for determining the interaction between C-reactive protein (CRP) and Clq, respectively, and for CRP and Clq binding components respectively, for concentration determination of a CRP and Cl of substances affecting the interaction of CRP and Clq, respectively, and to these binding components, especially the interaction between CRP and Clq.

NO20050037A 2002-06-12 2005-01-04 Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein NO20050037L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226011A DE10226011A1 (en) 2002-06-12 2002-06-12 HTS-capable method and test system for determining the interaction between c-reactive protein and components that bind to C-reactive protein
PCT/EP2003/006038 WO2003107000A2 (en) 2002-06-12 2003-06-10 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein

Publications (1)

Publication Number Publication Date
NO20050037L true NO20050037L (en) 2005-01-04

Family

ID=29718976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050037A NO20050037L (en) 2002-06-12 2005-01-04 Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein

Country Status (14)

Country Link
EP (1) EP1516187A2 (en)
JP (1) JP2005529348A (en)
CN (1) CN1745300A (en)
AR (1) AR040259A1 (en)
AU (1) AU2003250344A1 (en)
BR (1) BR0311709A (en)
CA (1) CA2489021A1 (en)
DE (1) DE10226011A1 (en)
MX (1) MXPA04012232A (en)
NO (1) NO20050037L (en)
RU (1) RU2005100042A (en)
TW (1) TW200411179A (en)
WO (1) WO2003107000A2 (en)
ZA (1) ZA200409199B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102721813A (en) * 2012-07-09 2012-10-10 沃克(天津)生物科技有限公司 Homogeneous luminous immunoassay assay kit for prostate specific antigen and detection method therefor
CN103852465A (en) * 2012-11-30 2014-06-11 通用电气公司 Method and apparatus for detecting marker protein
JP2018533017A (en) * 2015-10-02 2018-11-08 ティージーアール バイオサイエンシス ピーティーワイ エルティーディー． Specimen detection with multiple substrates
CN111398580B (en) * 2017-11-03 2023-06-13 科美诊断技术股份有限公司 Method for detecting target IgM antibody in sample
CN109752332A (en) * 2017-11-07 2019-05-14 重庆中元汇吉生物技术有限公司 A kind of C1Q detection kit
CN108490194A (en) * 2018-02-11 2018-09-04 北京科美生物技术有限公司 Detect the homogeneous immunological detection reagent suit and its preparation method and application of follicular stimulating hormone
CN108445238A (en) * 2018-02-11 2018-08-24 北京科美生物技术有限公司 Detect the homogeneous immunological detection reagent suit and its preparation method and application of interstitialcellstimulating hormone (ICSH)
CN108445216B (en) * 2018-02-11 2021-10-15 科美诊断技术股份有限公司 Human anti-mullerian hormone determination kit and preparation method and application thereof
CN108169497A (en) * 2018-02-11 2018-06-15 北京科美生物技术有限公司 Human prolactin detection kit and preparation method and application
CN108445239B (en) * 2018-02-11 2021-11-02 科美诊断技术股份有限公司 Homogeneous phase immunoassay reagent kit for detecting beta human chorionic gonadotropin, and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633488B2 (en) * 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
US6140490A (en) * 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
CA2170873A1 (en) * 1993-09-03 1995-03-09 Dariush Davalian Fluorescent oxygen channeling immunoassays
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes

Also Published As

Publication number Publication date
AR040259A1 (en) 2005-03-23
BR0311709A (en) 2005-03-15
CN1745300A (en) 2006-03-08
WO2003107000A3 (en) 2004-05-27
MXPA04012232A (en) 2005-02-25
TW200411179A (en) 2004-07-01
DE10226011A1 (en) 2004-01-08
ZA200409199B (en) 2005-05-18
AU2003250344A1 (en) 2003-12-31
CA2489021A1 (en) 2003-12-24
JP2005529348A (en) 2005-09-29
EP1516187A2 (en) 2005-03-23
WO2003107000A2 (en) 2003-12-24
RU2005100042A (en) 2006-07-20

Similar Documents

Publication Publication Date Title
NO20050037L (en) Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein
WO2006031883A3 (en) Analysis of mhc-peptide binding interactions
IS7611A (en) Microprocessor and method for performing a multiplicity of multiples of single microprocessor samples
DK1352238T3 (en) Method for Detecting Vitamin D Metabolites
WO2003073817A3 (en) Rapid and sensitive detection of cells and viruses
DE69308554T2 (en) IMPROVEMENTS IN OR RELATED TO ANALYTICAL EVIDENCE
DK1502102T3 (en) Compounds and Methods for Analyzing the Proteome
WO2008002615A3 (en) Method and system for determining mobile emissions reduction credits
NO20076662L (en) Detection of a malantigen independent of the presence or absence of a corresponding therapeutic antibody
ATE485514T1 (en) MULTIPLE ANALYTE IMMUNOASSAY
GB0625756D0 (en) Analyte delection system
NO20062309L (en) Method for processing seismic data acquired using multicomponent sensors
NO331074B1 (en) Assay Method for Determination of Holo-Transcobalamin II in a Cell-Free Sample in a Body Fluid.
WO2002008766A1 (en) Probe for analyzing protein-protein interaction and method of analyzing protein-protein interactions with the use of the same
NO964015L (en) Method for detecting calpain activation and identifying calpain inhibitors
ATE405837T1 (en) SOLID PHASE IMMUNOCHROMATOGRAPHIC TESTING METHODS
SE9502024D0 (en) Pathogen assay method
DE50105263D1 (en) METHOD FOR THE ANALYSIS OF PROTEINS
DK1644513T3 (en) Assay for protein binding detection
DE60033346D1 (en) PROCESS FOR DETERMINING CRP WITH THE HELP OF PHOSPHORYLCHOLIN
MX2019010478A (en) Systems and methods for enzymatic a1c detection and quantification.
DK1386160T3 (en) Method for detecting blood cell antigens and antibodies directed against them
ATE220098T1 (en) A PETROLEUM IMMUNE TESTING METHOD AND ITS COMPONENTS
DE69738503D1 (en) THE DETECTION OF OXIDIZED AND MDA-MODIFIED LIPOPROTEINS OF LESS DENSITY
ATE514078T1 (en) ANALYTICAL SYSTEM INCLUDING A SAMPLING AUTOMATIC ASSOCIATED WITH CHROMATOGRAPHIC ANALYSIS INSTRUMENTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application